Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E DOWLING

Showing results (391-400 of 406) with videos related to

Pageof 41
Sort By:
Scientific Reports|December 29, 2019
In Vivo Activity of Amodiaquine against Ebola Virus InfectionLisa Evans DeWald, Joshua C Johnson, Dawn M Gerhardt, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 20, 2019
Improving HIV Surveillance Data by Using the ATra Black Box System to Assist Regional Deduplication ActivitiesJoanne Michelle F Ocampo, Auntré Hamp, Anne Rhodes, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Monica S Montesinos, Yann Grobs, et al.
Circulation|January 20, 2025
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Mónica S Montesinos, Yann Grobs, et al.
Journal of Medicinal Chemistry|November 28, 2017
Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88<sup>L265P</sup> Diffuse Large B-Cell LymphomaJames S Scott, Sébastien L Degorce, Rana Anjum, et al.
Plos Pathogens|January 13, 2022
Advances and gaps in SARS-CoV-2 infection modelsCésar Muñoz-Fontela, Lina Widerspick, Randy A Albrecht, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2020
Optimization of a series of potent, selective and orally bioavailable SYK inhibitorsNeil P Grimster, Lakshmaiah Gingipalli, Bernard Barlaam, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2023
Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitorsNeil P Grimster, Lakshmaiah Gingipalli, Amber Balazs, et al.
Annals of the New York Academy of Sciences|October 2, 2022
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia reportJennifer Cable, Anthony Fauci, William E Dowling, et al.
Pageof 41

Showing results (391-400 of 406) with videos related to

Sort By:
Pageof 41
Scientific Reports|December 29, 2019
In Vivo Activity of Amodiaquine against Ebola Virus InfectionLisa Evans DeWald, Joshua C Johnson, Dawn M Gerhardt, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 20, 2019
Improving HIV Surveillance Data by Using the ATra Black Box System to Assist Regional Deduplication ActivitiesJoanne Michelle F Ocampo, Auntré Hamp, Anne Rhodes, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Monica S Montesinos, Yann Grobs, et al.
Circulation|January 20, 2025
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Mónica S Montesinos, Yann Grobs, et al.
Journal of Medicinal Chemistry|November 28, 2017
Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88<sup>L265P</sup> Diffuse Large B-Cell LymphomaJames S Scott, Sébastien L Degorce, Rana Anjum, et al.
Plos Pathogens|January 13, 2022
Advances and gaps in SARS-CoV-2 infection modelsCésar Muñoz-Fontela, Lina Widerspick, Randy A Albrecht, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2020
Optimization of a series of potent, selective and orally bioavailable SYK inhibitorsNeil P Grimster, Lakshmaiah Gingipalli, Bernard Barlaam, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2023
Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitorsNeil P Grimster, Lakshmaiah Gingipalli, Amber Balazs, et al.
Annals of the New York Academy of Sciences|October 2, 2022
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia reportJennifer Cable, Anthony Fauci, William E Dowling, et al.
Pageof 41